Nu Skin Enterprises, Inc. (NYSE:NUS)’s stock price gapped down before the market opened on Thursday after Citigroup lowered their price target on the stock from $86.00 to $52.00. The stock had previously closed at $42.37, but opened at $38.85. Citigroup currently has a buy rating on the stock. Nu Skin Enterprises shares last traded at $39.86, with a volume of 25,196 shares.
Several other equities research analysts also recently commented on the stock. DA Davidson boosted their target price on shares of Commerce Bancshares to $62.00 and gave the stock a “neutral” rating in a research report on Wednesday. Bank of America cut their price target on shares of Canopy Growth from $80.00 to $75.00 and set a “buy” rating on the stock in a report on Wednesday, June 19th. Stifel Nicolaus set a $99.00 target price on shares of C.H. Robinson Worldwide and gave the company a “hold” rating in a research note on Monday, March 25th. Zacks Investment Research cut shares of Inflarx from a “buy” rating to a “hold” rating in a research note on Friday, May 3rd. Finally, Deutsche Bank cut shares of Hilton Hotels from a “buy” rating to a “hold” rating and set a $92.60 price target on the stock. in a research note on Wednesday, May 1st. They noted that the move was a valuation call. Three research analysts have rated the stock with a sell rating, three have assigned a hold rating and four have assigned a buy rating to the company’s stock. Nu Skin Enterprises currently has a consensus rating of “Hold” and an average price target of $55.63.
A number of large investors have recently modified their holdings of NUS. Quadrant Capital Group LLC lifted its holdings in shares of Nu Skin Enterprises by 823.3% in the first quarter. Quadrant Capital Group LLC now owns 554 shares of the company’s stock worth $26,000 after buying an additional 494 shares in the last quarter. YorkBridge Wealth Partners LLC purchased a new stake in shares of Nu Skin Enterprises during the fourth quarter valued at $31,000. Meeder Asset Management Inc. purchased a new stake in shares of Nu Skin Enterprises during the first quarter valued at $65,000. Investors Research Corp purchased a new stake in Nu Skin Enterprises in the first quarter worth about $73,000. Finally, Exane Derivatives purchased a new stake in Nu Skin Enterprises in the second quarter worth about $82,000. 77.17% of the stock is currently owned by institutional investors and hedge funds.
Nu Skin Enterprises (NYSE:NUS) last posted its quarterly earnings data on Tuesday, April 30th. The company reported $0.77 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.71 by $0.06. Nu Skin Enterprises had a net margin of 4.82% and a return on equity of 26.81%. The firm had revenue of $623.60 million for the quarter, compared to the consensus estimate of $615.98 million. During the same quarter in the prior year, the company posted $0.79 earnings per share. The company’s revenue for the quarter was up 1.2% compared to the same quarter last year. As a group, research analysts forecast that Nu Skin Enterprises, Inc. will post 3.92 earnings per share for the current year.
Nu Skin Enterprises Company Profile (NYSE:NUS)
Nu Skin Enterprises, Inc develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic and personal care products.
Further Reading: What is a recession?
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.